|Karen P. Briski, Department Head and Professor of Pharmacology
Ph.D., University of Michigan, 1981
Postdoctoral, Michigan State University
Research: Neuroanatomical and neurochemical substrates for central glucoprivic regulation of reproductive neuroendocrine function and food intake, with emphasis on caudal brain stem catecholaminergic, glutaminergic, and nitregic signaling.
|Khalid A. El Sayed, Professor of Medicinal and Natural Products Chemistry
Ph. D., Mansoura University (Egypt)
Postdoctoral, University of Mississippi
Research: Isolation and characterization of bioactive plant and marine-derived natural products. Use of microbial and chemical transformations as tools to broaden the bioactivity and chemistry scopes of these natural products.
|Ronald A. Hill, Associate Professor of Medicinal Chemistry
Ph. D., Ohio State University, 1991
Research: Chiral amino acid synthesis and analysis, heterocyclic chemistry, synthesis of excitatory amino acid antagonists, CNS riboflavin metabolism, CNS potassium channel modulators.
|Keith Jackson, Assistant Professor of Pharmacology
Ph.D., University of North Texas HSC at Fort Worth, 2001
Postdoctoral, University of North Texas, Tulane University HSC
Research: Cardiovascular function, renal hemodynamics and clearance, mechanisms of hypertension, and biological roles for porphyrin and gaseous messengers.
|Seetharama Jois, Professor of Medicinal Chemistry
Ph.D., Indian Institute of Science, Bangalore, India, 1994
Research: Design and structural studies of peptides for cell-adhesion inhibition. Design of small molecular inhibitors targeted towards HER-2 as therapeutic agents for breast and lung cancer.
|Amal Khalil Kaddoumi, Associate Professor of Pharmaceutics
Ph.D., Nagaski University, Nagaski, Japan, 2004
|Yong-Yu Liu, Professor of Pharmacology
M.D., Soochow University School of Medicine, 1984
Ph.D., Shanghai University of Traditional Chinese Medicine, 1989
Postdoctoral, University of Rome-Tor Vergata, University of Manitoba, John Wayne Cancer Institute
Research: Tumor cell response to chemotherapy, sphingolipid glycosylation and gene regulation.
|Georgios Matthaiolampakis, Assistant Professor of Pharmaceutics
B.S. in Chemical Engineering, National Technical University of Athens, Greece, 2005
Research: Using polymer-based nanomedicine to promote scientific knowledge in cancer treatment
|Sami M. Nazzal, Associate Professor of Pharmaceutics
Ph.D., Texas Tech University Health Sciences Center 2002
Research: Modified and controlled drug release. Coating and manufacturing process development. Lipid based drug delivery and lipolysis modeling.
|Girish Shah, Mary E. and Darrell L. Calhoun Endowed Chair and Professor of Pharmacology
Ph.D., University of Bombay, 1979
Postdoctoral Karolinska Institute, Max Planck Clinical Research Unit for Reproductive Medicine, and Department of Biochemistry, McMaster University
Research: The role of calcitonin in the progression of prostate carcinoma with the aim of development of new therapeutic approaches. Studies directed toward understanding the role of pituitary calcitonin in the development of the pituitary gland as well as in the process of overall growth and development.
|Paul W. Sylvester, B. J. Robison/Pfizer Endowed Professor of Pharmacology
Ph.D., Michigan State University, 1982
Postdoctoral, Roswell Park Cancer Institute
Research: Neuroendocrinology and endocrine-dependent cancers, particularly breast cancer prevention and etiology. Intracellular signaling mechanisms mediating normal and neoplastic mammary epithelial cell proliferation and apoptosis.
|Ruthie Sampson, Administrative Assistant|